-
4
-
-
58449099582
-
The next-generation pharmaceutical value chain
-
Anon
-
Anon (2004) The next-generation pharmaceutical value chain. An Arthur D. Little Industry Forum, 2004, pp. 1-18.
-
(2004)
An Arthur D. Little Industry Forum
, vol.2004
, pp. 1-18
-
-
-
5
-
-
58449099861
-
Briefing pharmaceuticals: Billion dollar pills
-
Anon
-
Anon (2007) Briefing pharmaceuticals: Billion dollar pills. The Economist
-
(2007)
The Economist
-
-
-
6
-
-
58449095358
-
-
Balaban, R., Chadwick-Jones, A., Creehan, K., Bonifant, B. and Campbell, D. (2003) Executive briefing-pharma trends 1.
-
(2003)
Executive Briefing-pharma Trends 1
-
-
Balaban, R.1
Chadwick-Jones, A.2
Creehan, K.3
Bonifant, B.4
Campbell, D.5
-
8
-
-
0030000823
-
Participation of life-science faculty in research relationships with industry
-
Blumenthal, D., Campbell, E. G., Causino, N. and Louis, K. S. (1996) Participation of life-science faculty in research relationships with industry. The New England Journal of Medicine, 335, pp. 1734-1739.
-
(1996)
The New England Journal of Medicine
, vol.335
, pp. 1734-1739
-
-
Blumenthal, D.1
Campbell, E.G.2
Causino, N.3
Louis, K.S.4
-
10
-
-
20444437996
-
The origins and evolution of scenario techniques in long range business planning
-
Bradfield, R., Wright, G., Burt, G., Cairns, G. and van der Heijden, K. (2006) The origins and evolution of scenario techniques in long range business planning. Futures, 37, pp. 795-812.
-
(2006)
Futures
, vol.37
, pp. 795-812
-
-
Bradfield, R.1
Wright, G.2
Burt, G.3
Cairns, G.4
van der Heijden, K.5
-
13
-
-
58449096937
-
Pharmaceutical industry success dependent upon better product lifecycle management
-
Capgemini
-
Capgemini (2004) Pharmaceutical industry success dependent upon better product lifecycle management. Capgemini News
-
(2004)
Capgemini News
-
-
-
14
-
-
58449122417
-
Climbing the helical staircase: A survey of biotechnology
-
Carr, G. (2003) Climbing the helical staircase: A survey of biotechnology. The Economist, pp. 1-20.
-
(2003)
The Economist
, pp. 1-20
-
-
Carr, G.1
-
17
-
-
0037374498
-
The cost of new drug discovery and development
-
DiMasi, J. A., Hansen, R. W. and Grabowski, H. G. (2003) The cost of new drug discovery and development. Journal of Health Economics, 22, pp. 151-185.
-
(2003)
Journal of Health Economics
, vol.22
, pp. 151-185
-
-
DiMasi, J.A.1
Hansen, R.W.2
Grabowski, H.G.3
-
19
-
-
58449098345
-
-
European Federation of Pharmaceutical Industries and Associations
-
European Federation of Pharmaceutical Industries and Associations (2007) The pharmaceutical industry in figures - key data - 2007 update. European Federation of Pharmaceutical Industries and Associations, Brussels, Belgium
-
(2007)
The Pharmaceutical Industry in Figures - Key Data - 2007 Update
-
-
-
20
-
-
58449127718
-
The pharmaceutical industry: A look to the future
-
Farrugia, C. A. (2004) The pharmaceutical industry: A look to the future. Industry Today, 56, pp. 40-41.
-
(2004)
Industry Today
, vol.56
, pp. 40-41
-
-
Farrugia, C.A.1
-
21
-
-
34347366477
-
Prescription for change: A survey of the pharmaceuticals
-
Feki, S. E. (2005) Prescription for change: A survey of the pharmaceuticals. The Economist
-
(2005)
The Economist
-
-
Feki, S.E.1
-
22
-
-
58449118217
-
Early warnings: Business tsunamis are approaching. Learn how to prepare
-
Fuld, L. (2004) Early warnings: Business tsunamis are approaching. Learn how to prepare. Pharmaceutical Executive
-
(2004)
Pharmaceutical Executive
-
-
Fuld, L.1
-
24
-
-
0004186401
-
-
Harvard Business School Press, Boston, MA
-
Hamel, G. (2000) Leading the revolution, Harvard Business School Press, Boston, MA
-
(2000)
Leading the Revolution
-
-
Hamel, G.1
-
25
-
-
77949835940
-
The pharmaceutical market outlook to 2015: Implementing innovative long-term strategies for sustainable future growth
-
Hamilton, G. (2005) The pharmaceutical market outlook to 2015: implementing innovative long-term strategies for sustainable future growth. Business Insights
-
(2005)
Business Insights
-
-
Hamilton, G.1
-
26
-
-
58449103768
-
Bristol-Meyers falling profits caused by generic competition
-
Harrison, V. (2006) Bristol-Meyers falling profits caused by generic competition. Pharmaceutical Business Review
-
(2006)
Pharmaceutical Business Review
-
-
Harrison, V.1
-
27
-
-
58449112084
-
Globalisation and equitable access to essential drugs
-
Hoen, E. (2002) Globalisation and equitable access to essential drugs. TWNThird World Network
-
(2002)
TWNThird World Network
-
-
Hoen, E.1
-
28
-
-
77749304219
-
The pharmaceutical market outlook to 2010: Essential analysis of key drivers of change
-
Jackson, D. (2003) The pharmaceutical market outlook to 2010: Essential analysis of key drivers of change. Business Insights
-
(2003)
Business Insights
-
-
Jackson, D.1
-
30
-
-
84984499960
-
Inferential processes in the construction of scenarios
-
Jungermann, H. (1985) Inferential processes in the construction of scenarios. Journal of Forecasting, 4, pp. 321-327.
-
(1985)
Journal of Forecasting
, vol.4
, pp. 321-327
-
-
Jungermann, H.1
-
32
-
-
1542501021
-
The biotech future
-
Rabino, I. (1998) The biotech future. American Scientist Online, 85:2, pp. 110-113.
-
(1998)
American Scientist Online
, vol.85
, Issue.2
, pp. 110-113
-
-
Rabino, I.1
-
33
-
-
58449085974
-
Govt to import generic versions of heart drug
-
Treerutkuarkul, A. (2007) Govt to import generic versions of heart drug. Bangkok Post, p. 2.
-
(2007)
Bangkok Post
, pp. 2
-
-
Treerutkuarkul, A.1
-
35
-
-
0141780704
-
-
John Wiley, Chichester, UK
-
Van der Heijden, K., Bradfield, R. M., Burt, G., Cairns, G. and Wright, G. (2002) The sixth sense: Accelerating organisational learning with scenarios, John Wiley, Chichester, UK
-
(2002)
The Sixth Sense: Accelerating Organisational Learning With Scenarios
-
-
Van der Heijden, K.1
Bradfield, R.M.2
Burt, G.3
Cairns, G.4
Wright, G.5
-
36
-
-
0028922794
-
Diagnosing the decline of major pharmaceutical research laboratories: A prescription for drug companies
-
Weisbach, J. and Moos, H. W. (1995) Diagnosing the decline of major pharmaceutical research laboratories: A prescription for drug companies. Drug Development Research, 34, pp. 243-259.
-
(1995)
Drug Development Research
, vol.34
, pp. 243-259
-
-
Weisbach, J.1
Moos, H.W.2
-
37
-
-
33747809088
-
Why organisations are slow to adapt and change - And what can be done about it
-
Wright, G., van der Heijden, K., Bradfield, R., Burt, G. and Cairns, G. (2004) Why organisations are slow to adapt and change - and what can be done about it. Journal of General Management, 29:4, pp. 20-35.
-
(2004)
Journal of General Management
, vol.29
, Issue.4
, pp. 20-35
-
-
Wright, G.1
van der Heijden, K.2
Bradfield, R.3
Burt, G.4
Cairns, G.5
|